問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
林怡瑄
下載
2024-04-01 - 2028-08-03
Condition/Disease
xxxxxx
Test Drug
Participate Sites5Sites
Recruiting5Sites
2025-07-01 - 2028-12-31
-Change from baseline in seated Systolic Blood Pressure (SBP) at Week 8 -Achieving normalization of the Renin Angiotensin Aldosterone system (RAAS) at week 8
Baxdrostat
Participate Sites6Sites
Recruiting6Sites
2023-04-01 - 2032-12-31
Primary Prevention of Atherosclerotic Cardiovascular Disease
KJX839 (Inclisiran)
Participate Sites9Sites
Recruiting9Sites
2022-12-01 - 2025-08-31
2022-10-11 - 2024-12-31
全部
